YOLFTbeta
Establishment Labs Holdings Inc

Establishment Labs Holdings Inc

ESTA · NASDAQ · Healthcare / Medical Devices

70.75USD+2.13 (+3.10%)

Price History

Full chart

Market Stats

Previous Close68.62
Open68.98
Day Range67.56 – 71.58
52-Week Range38.35 – 97.59
Volume364.69K
Market Cap1.97B
P/E (TTM)0.00
Forward P/E204.08
EPS-1.27
Dividend Yield0.00%
Beta1.05
50-Day Avg78.72
200-Day Avg73.48

About

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Fillipo Peter Caldini
  • Employees1.00K
  • Headquarters11401 century oaks terrace, Austin, TX, United States, 78758, USA
  • Websitehttps://www.establishmentlabs.com

Leadership

  • Mr. Fillipo Peter CaldiniCEO & Director · b. 1965
  • Mr. S. Ross MansbachGeneral Counsel, Chief Compliance Officer & Chief Human Resources Officer · b. 1967
  • Ms. Cassandra E. HarrisSenior VP & CFO · b. 1973
  • Mr. Roberto de MezervilleChief Technology Officer · b. 1980
  • Ms. Malavika WilliamVP, Global Head of Marketing & Communications
  • Mr. Ivan BilicSenior Vice President of Commercial Operations - OUS
  • Mr. Jeff EhrhardtSenior VP & GM of North America

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue9.59M19.80M34.68M61.21M89.56M84.68M126.68M161.70M165.15M166.03M211.08M
Growth (%)-+106.39%+75.15%+76.49%+46.33%-5.46%+49.61%+27.64%+2.13%+0.53%+27.14%
Cost of Revenue4.62M9.71M16.98M25.09M34.70M32.17M41.28M55.10M58.17M56.50M64.77M
Gross Profit4.97M10.10M17.70M36.12M54.86M52.50M85.40M106.59M106.98M109.53M146.31M
Gross Margin51.81%50.99%51.04%59.01%61.25%62.00%67.42%65.92%64.78%65.97%69.32%
Operating Expense5.33M25.93M37.69M59.98M85.80M80.42M110.54M146.25M172.00M159.51M185.32M
Operating Income-360.00K-15.83M-19.98M-23.86M-30.94M-27.92M-25.14M-39.66M-65.03M-49.99M-39.01M
Operating Margin-3.75%-79.96%-57.62%-38.99%-34.55%-32.97%-19.84%-24.53%-39.37%-30.11%-18.48%
EBITDA--18.02M-22.43M-9.27M-25.51M-24.93M-26.54M-56.90M-58.31M-56.22M-22.29M
EBITDA Margin--91.01%-64.68%-15.14%-28.49%-29.45%-20.95%-35.19%-35.31%-33.86%-10.56%
Net Income-1.59M-22.16M-34.90M-21.10M-38.15M-38.12M-41.14M-75.21M-78.50M-84.60M-51.06M
Net Income Margin-16.61%-111.91%-100.62%-34.47%-42.59%-45.02%-32.47%-46.51%-47.53%-50.95%-24.19%
R&D-2.74M6.86M12.69M14.99M13.79M18.32M20.27M26.43M19.71M20.25M
R&D as % of Total Revenue-13.84%19.79%20.73%16.74%16.29%14.46%12.53%16.00%11.87%9.59%
Interest Expense03.41M10.42M8.81M8.70M9.37M9.06M11.76M15.39M20.83M25.26M
Interest Expense % of Total Revenue0.00%17.24%30.05%14.40%9.71%11.07%7.15%7.27%9.32%12.55%11.97%

Balance Sheet

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-29.56M57.09M116.57M116.53M156.39M139.53M211.06M268.64M346.83M357.17M
Total Liabilities-56.00M62.11M47.09M76.92M81.43M88.79M219.25M250.25M293.74M333.62M
Total Equity--26.43M-5.01M69.48M39.61M74.96M50.74M-8.19M18.39M53.09M23.55M
Cash-479.00K10.86M52.64M37.66M84.52M53.41M66.36M40.03M90.35M75.57M
Total Debt-38.15M24.09M27.54M48.40M52.54M54.21M179.35M192.22M225.29M264.47M
Net Debt-37.67M13.22M-30.32M10.49M-31.98M793.00K112.99M152.19M134.95M188.90M

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-14.27M-31.97M-33.88M-29.98M-12.51M-27.53M-52.17M-88.51M-58.52M-50.89M
Investing Cash Flow-10.76M-845.00K-5.73M-7.77M-5.56M-7.16M-34.79M-24.55M-15.61M-7.03M
Financing Cash Flow20.21M42.99M81.53M22.79M64.67M4.05M100.25M86.23M125.89M40.43M
Capital Expenditure10.55M941.00K1.77M7.00M3.91M6.73M34.27M24.55M15.56M6.72M
Free Cash Flow-24.82M-32.91M-35.66M-36.98M-16.42M-34.26M-86.43M-113.06M-74.08M-57.61M
Dividends Paid-36.06M-1.72M154.00K4.23M3.87M---
FCF to OCF173.98%102.94%105.23%123.34%131.23%124.44%165.69%127.73%126.59%113.21%
Dividend Paid to FCF--109.58%--4.64%-0.94%-12.34%-4.48%---

Earnings

Report DateApr 11, 2018Aug 14, 2018Nov 13, 2018Mar 20, 2019May 15, 2019Aug 13, 2019Nov 12, 2019Mar 16, 2020May 7, 2020Aug 6, 2020Nov 9, 2020Mar 10, 2021May 5, 2021Jul 29, 2021Nov 9, 2021Mar 1, 2022May 9, 2022Aug 8, 2022Nov 7, 2022Feb 27, 2023May 8, 2023Aug 8, 2023Nov 7, 2023Feb 28, 2024May 8, 2024Aug 6, 2024Nov 7, 2024Feb 26, 2025May 7, 2025Aug 7, 2025Nov 5, 2025Mar 4, 2026May 6, 2026Aug 6, 2026Nov 4, 2026
EPS Estimate0.00-0.40-0.51-0.36-0.46-0.53-0.50-0.54-0.31-0.48-0.34-0.19-0.34-0.28-0.35-0.33-0.38-0.40-0.53-0.68-0.69-0.71-0.76-0.91-0.65-0.51-0.61-0.66-0.83-0.54-0.54-0.22-0.38-0.34-0.32
EPS Actual-1.95-0.350.10-0.52-0.53-0.44-0.62-0.27-0.79-0.45-0.18-0.23-0.29-0.22-0.61-0.60-0.24-1.52-0.76-0.55-0.48-0.65-1.12-0.79-0.58-0.62-0.59-1.19-0.70-0.57-0.38-0.09-0.40-0.39-
Surprise-12.50%119.61%-44.44%-15.22%16.98%-24.00%50.00%-154.84%6.25%47.06%-21.05%14.71%21.43%-74.29%-81.82%36.84%-280.00%-43.40%19.12%30.43%8.45%-47.37%13.19%10.77%-21.57%3.28%-81.40%15.66%-5.56%29.63%59.64%-5.26%-14.71%-
Timing-After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap1.97B
Enterprise Value2.21B
Trailing P/E0.00
Forward P/E204.08
Price / Sales8.00
Price / Book93.32
EPS-1.27
Book Value0.725
Revenue (TTM)245.82M
Gross Profit (TTM)173.27M
EBITDA-8.98M
Profit Margin-15.82%
Operating Margin-6.35%
Return on Equity-175.30%
Return on Assets-3.44%
Shares Outstanding29.80M
Shares Float19.53M
Beta1.05
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 8 analystsTarget 102.44
  • Strong Buy
    5
  • Buy
    2
  • Hold
    1

Ownership Breakdown

Institutions
105.73%
Insiders
10.03%
Retail / Other
0.00%

Top Institutional Holders

  • JW Asset Management, LLC
    2.69M9.04%
  • RTW INVESTMENTS, LLC
    2.66M8.91%
  • Brown Advisory Holdings Inc
    1.53M5.12%
  • Findell Capital Management LLC
    1.10M3.68%
  • BAMCO Inc
    964.17K3.24%
  • Nantahala Capital Management, LLC
    832.96K2.79%
  • Mudita Advisors LLP
    764.56K2.57%
  • William Blair Investment Management, LLC
    714.05K2.40%
  • The Goldman Sachs Group Inc
    632.28K2.12%
  • Jane Street Group LLC
    627.70K2.11%
  • Tyro Capital Management LLC
    605.56K2.03%
  • D. E. Shaw & Co LP
    566.91K1.90%
  • Rice Hall James & Associates, LLC
    560.93K1.88%
  • The Toronto-Dominion Bank
    540.02K1.81%
  • BRAIDWELL LP
    463.60K1.56%
  • Two Sigma Investments LLC
    448.43K1.50%
  • Royce & Associates, LP
    427.47K1.43%

Top Fund Holders

  • iShares Russell 2000 ETF
    689.53K2.31%
  • T. Rowe Price New Horizons
    488.75K1.64%
  • Loomis Sayles Small Cap Growth Instl
    455.67K1.53%